Safety, Tolerability and Pharmacokinetics of TAK-438 in Healthy Male Participants

NCT02123927 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Ascending Single Dose Study

Interventions

DRUG: TAK-438
DRUG: Placebo

Sponsor

Takeda